Skip to main content
Article
PHASE I/II TRIAL OF 5-FLUOROURACIL, LEUCOVORIN, ZIDOVUDINE AND DIPYRIDAMOLE FOR PATIENTS WITH METASTATIC COLORECTAL-CANCER, RENAL-CELL CARCINOMA AND MALIGNANT-MELANOMA
International Journal of Oncology (1995)
  • W. H. Sharfman, National Institutes of Health
  • W. J. Urba, National Institutes of Health
  • J. W. Smith, National Institutes of Health
  • J. E. Janik, National Institutes of Health
  • B. D. Curti, National Institutes of Health
  • B. L. Gause, National Institutes of Health
  • J. T. Holmlund, National Institutes of Health
  • R. G. Steis, National Institutes of Health
  • A. E. Beauchamp, National Institutes of Health
  • D. L. Longo, National Institutes of Health
Publication Date
March 1, 1995
DOI
10.3892/ijo.6.3.579
Citation Information
W. H. Sharfman, W. J. Urba, J. W. Smith, J. E. Janik, et al.. "PHASE I/II TRIAL OF 5-FLUOROURACIL, LEUCOVORIN, ZIDOVUDINE AND DIPYRIDAMOLE FOR PATIENTS WITH METASTATIC COLORECTAL-CANCER, RENAL-CELL CARCINOMA AND MALIGNANT-MELANOMA" International Journal of Oncology Vol. 6 Iss. 3 (1995) p. 579 - 583
Available at: http://works.bepress.com/walter-urba/37/